Research

U-M Division of Pulmonary & Critical Care Medicine Researchers

Research performed within the Division of Pulmonary & Critical Care Medicine has greatly impacted our understanding of basic lung biology, disease pathogenesis, and targeted therapeutics. NIH grant funding for research within the Division exceeds 13 million dollars annually. Our investigative portfolio is comprehensive, with specific areas of emphasis including pulmonary inflammation, lung injury and repair, fibrotic lung disorders, host defense, lung transplantation, and lung cancer. 

New major areas of modern biology have emerged, including genetics/genomics, metagenomics, proteomics, metabolomics, stem cell biology, computational biology, and the microbiome. Researchers in the division participate in large multidisciplinary and multicenter disease-specific programs and networks in interstitial lung disease (IPFnet, COMET, LTRC), COPD (SPIROMICS, COPD gene, LTRC), and Acute Lung Injury (SCOR, SCCOR, ARDSnet). 

Emerging fields of patient-oriented research have been added or expanded, including health services research and sleep. Active areas of health services research include long-term functional outcomes in survivors of critical illness, nosocomial infection, delirium in the ICU, health care utilization, and health care policy.

Research Highlights

Short Hospitalizations Hit Hard for COVID Patients

Theodore J. Iwashyna, MD, PhD and team find that even after a short stay in the hospital, COVID-19 patients experienced significant long-term health and financial impacts.

Teamwork Saves Lives: COVID-19 Hospital Network Shares Key Lessons to Improve Care

Learning from real-time data from 40 Michigan hospitals reduced wide variation in everything from antibiotic use to clot prevention, and yielded findings that could be used worldwide.

Deep Learning Algorithm Detects Acute Respiratory Distress Syndrome with Expert-Level Accuracy

Michael Sjoding, MD and team develop a new artificial intelligence algorithm that analyzes chest x-rays for ARDS.